-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2017 to 2023.
- Aptose Biosciences Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2024 was $2.01M.
- Aptose Biosciences Inc. Net Cash Provided by (Used in) Investing Activities for the twelve months ending June 30, 2024 was $14.9M, a 96.7% increase year-over-year.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $9.96M, a 66.9% decline from 2022.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $30.1M.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$35.2M, a 379% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)